Changes to the Continuous Glucose Monitoring (CGM) Initiative

6 Feb 2020

AMA members are advised that there are changes to the Australian Government’s Continuous Glucose Monitoring (CGM) Initiative delivered as part of the National Diabetes Services Scheme (NDSS).

From 1 March 2020, the range of products subsidised under the CGM Initiative will be expanded to include the FreeStyle Libre Flash Glucose Monitoring System. The eligibility criteria for the CGM Initiative will also be streamlined to remove the ‘high clinical need’ requirement for people with type 1 diabetes who are 21 years of age or older and who have concessional status.

All products supplied through the CGM Initiative will continue to be fully subsidised with no patient copayment. The selection of products for individual users will continue to be a decision for health professionals in consultation with their patient.

Details on products currently subsidised under the CGM Initiative are available here.

The expanded eligibility criteria for the CGM Initiative from 1 March 2020 includes:

  • children and young people, under 21 years of age, with type 1 diabetes;
  • children and young people with conditions very similar to type 1 diabetes, such as cystic fibrosis related diabetes and neonatal diabetes, who require insulin;
  • women with type 1 diabetes who are planning for pregnancy, pregnant, or immediately post-pregnancy; and
  • people with type 1 diabetes aged 21 years or older who have concessional status.

You can access further information about the CGM Initiative, including the full eligibility criteria, list of available products and application process, from the NDSS website here or by calling the NDSS Helpline on 1300 136 588.